Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1998 1
2001 1
2002 1
2011 2
2012 1
2013 1
2014 1
2016 1
2018 1
2019 2
2020 4
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype.
Llanos AAM, Lin Y, Chen W, Yao S, Norin J, Chekmareva MA, Omene C, Cong L, Omilian AR, Khoury T, Hong CC, Ganesan S, Foran DJ, Higgins M, Ambrosone CB, Bandera EV, Demissie K. Llanos AAM, et al. Among authors: omene c. Breast Cancer Res. 2020 Feb 11;22(1):18. doi: 10.1186/s13058-020-1256-3. Breast Cancer Res. 2020. PMID: 32046756 Free PMC article.
Prediagnostic Allostatic Load as a Predictor of Poorly Differentiated and Larger Sized Breast Cancers among Black Women in the Women's Circle of Health Follow-Up Study.
Xing CY, Doose M, Qin B, Lin Y, Plascak JJ, Omene C, He C, Demissie K, Hong CC, Bandera EV, Llanos AAM. Xing CY, et al. Among authors: omene c. Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):216-224. doi: 10.1158/1055-9965.EPI-19-0712. Epub 2019 Nov 12. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31719063 Free PMC article.
Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features.
Llanos AAM, Yao S, Singh A, Aremu JB, Khiabanian H, Lin Y, Omene C, Omilian AR, Khoury T, Hong CC, Ganesan S, Foran DJ, Higgins MJ, Ambrosone CB, Bandera EV, Demissie K. Llanos AAM, et al. Among authors: omene c. Breast Cancer Res Treat. 2021 Feb;185(3):785-798. doi: 10.1007/s10549-020-05972-0. Epub 2020 Oct 16. Breast Cancer Res Treat. 2021. PMID: 33067778
Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer.
Singh J, Novik Y, Stein S, Volm M, Meyers M, Smith J, Omene C, Speyer J, Schneider R, Jhaveri K, Formenti S, Kyriakou V, Joseph B, Goldberg JD, Li X, Adams S, Tiersten A. Singh J, et al. Among authors: omene c. Breast Cancer Res. 2014 Mar 31;16(2):R32. doi: 10.1186/bcr3634. Breast Cancer Res. 2014. PMID: 24684785 Free PMC article. Clinical Trial.
16 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page